window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : October 4, 2025

  • News
  • About Us
Contact Us

predictive medicine

  • Artificial Intelligence,Clinical Trials,Digital Health,Drug Development,Global health,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    QuantHealth secures strategic investment from Sanofi Ventures to accelerate AI-driven clinical trials

    QuantHealth, a pioneer in AI-driven clinical trial simulation, has received [...]

    October 1, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • HeliosX strengthens leadership team to drive global growth and brand innovation
    Categories: Digital Health, Global health, Market Access & Commercialization, Movers & Shakers, Patient Centricity, Pharmaceuticals and therapeutics, Technology and platforms
  • SeaBeLife secures €2 million to advance dual-targeted therapies for dry AMD and severe acute hepatitis
    Categories: Biotech, Clinical Development, Clinical Trials, Drug Development, Global health, Partnerships & Funding, Rare Diseases, Research & Development
  • Amorphical reports positive interim results from ongoing Crohn’s disease trial
    Categories: Chronic diseases, Clinical Development, Clinical studies, Clinical Trials, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top